IDH1 and colorectal cancer: SIRT2 deacetylates IDH1 at K224, promoting its enzymatic activity and α‐ketoglutarate production and inhibiting the invasion and migration of CRC cells, while high acetylation of IDH1 at K224 is significantly associated with distant metastasis and survival in colorectal cancer patients.259